Preliminary unaudited net revenues from global sales of IMCIVREE®(setmelanotide) of approximately $42 million for the fourth quarter of 2024 ...

As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" ...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals ... creating potentially transformative options that enable people living with devastating rare diseases to experience long and full ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In fact, active pharmaceutical ingredients (APIs) alone made up 70% of these emissions. The evidence reveals the need for investment in R&D for greener API manufacturing, as well as more sustainable ...

Enter the necessary details and complete the captcha. Senores Pharmaceuticals has been performing well in the grey market, even amidst market volatility. The IPO was commanding a premium of Rs 240 in ...

Senores Pharmaceuticals is a pharmaceutical company that develops and manufactures a variety of products for regulated markets such as the US, Canada, and the UK, as well as emerging markets. The IPO ...

1 Day 603351 -0.97% DJIA 1.18% S&P Mid Cap 400 0.60% Basic Materials/Resources 0.81% ...

And now the company said it plans to revolutionize the way pharmaceutical deliveries are made in Hampton Roads, the Mid-Atlantic states and beyond with its automated last-mile delivery system.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Brookdale Senior Living (BKD – Research Report), Santhera Pharmaceuticals Holding (SPHDF ...

The country exports pharmaceutical products to at least 151 countries, including those in the EU, Africa and Latin America as well as the US, after catering to 98 percent of the domestic demand ...